Lantheus Holdings (LNTH) Acquisitions (2025)

Lantheus Holdings' (LNTH) quarterly Acquisitions came in at $37.8 million in Q4 2025, up 23009.09% on a QoQ basis from -$165000.0 in Q3 2025.

Lantheus Holdings (LNTH) Acquisitions (2025) Analysis & Trends

Lantheus Holdings (LNTH) has 1 years of Acquisitions data on file, last reported at $37.8 million in Q4 2025.

On a quarterly basis, Acquisitions changed N/A year-over-year to $37.8 million in Q4 2025; TTM through Mar 2026 was $256.7 million, a 413.47% increase from a year earlier, with the FY2025 full-year figure at $306.7 million, changed N/A from the prior year.
Acquisitions for Q4 2025 stood at $37.8 million, up from -$165000.0 in the prior quarter.
Over the last five years, Acquisitions for LNTH reached as high as $219.1 million in Q2 2025 and fell as low as -$165000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Lantheus Holdings	6.72 Bn	6.22 Bn	230.92 Mn	-

Download Data